<DOC>
	<DOCNO>NCT00092560</DOCNO>
	<brief_summary>The purpose study evaluate cholesterol lower effectiveness safety two investigational drug patient mixed hyperlipidemia ( high cholesterol high triglyceride ) .</brief_summary>
	<brief_title>Two Investigational Drugs Patients With Mixed Hyperlipidemia ( 0653-036 )</brief_title>
	<detailed_description>The duration treatment 18 week .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Hyperlipidemia , Familial Combined</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type V</mesh_term>
	<mesh_term>Lipidoses</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>High cholesterol high triglyceride Patient condition , opinion investigator , might pose risk patient , interfere participation study , meet additional criterion require study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>mixed hyperlipidemia</keyword>
	<keyword>high cholesterol</keyword>
	<keyword>high triglyceride</keyword>
</DOC>